Heterogeneous nuclear ribonucleoprotein K and nucleolin as transcriptional activators of the vascular endothelial growth factor promoter through interaction with secondary DNA structures.
暂无分享,去创建一个
Daekyu Sun | Yoon-Joo Shin | K. Guo | Daekyu Sun | Kexiao Guo | Diana J Uribe | Yoon-Joo Shin | Diana J. Uribe | Y. Shin
[1] A. Phan,et al. Propeller-type parallel-stranded G-quadruplexes in the human c-myc promoter. , 2004, Journal of the American Chemical Society.
[2] G. Semenza,et al. Activation of vascular endothelial growth factor gene transcription by hypoxia-inducible factor 1 , 1996, Molecular and cellular biology.
[3] L. Hurley,et al. The role of supercoiling in transcriptional control of MYC and its importance in molecular therapeutics , 2009, Nature Reviews Cancer.
[4] David Levens,et al. Heterogeneous nuclear ribonucleoprotein K is a transcription factor , 1996, Molecular and cellular biology.
[5] R. Natarajan,et al. Distinct Roles of Heterogeneous Nuclear Ribonuclear Protein K and microRNA-16 in Cyclooxygenase-2 RNA Stability Induced by S100b, a Ligand of the Receptor for Advanced Glycation End Products*♦ , 2008, Journal of Biological Chemistry.
[6] L. Hurley,et al. Intramolecularly folded G-quadruplex and i-motif structures in the proximal promoter of the vascular endothelial growth factor gene , 2008, Nucleic acids research.
[7] Mauro Ferrari,et al. Morphologic Instability and Cancer Invasion , 2005, Clinical Cancer Research.
[8] C. Burrows,et al. Cytosine-specific chemical probing of DNA using bromide and monoperoxysulfate. , 1996, Nucleic acids research.
[9] D. Levens,et al. The functional response of upstream DNA to dynamic supercoiling in vivo , 2008, Nature Structural &Molecular Biology.
[10] M. Biggin,et al. The specificity of protein-DNA crosslinking by formaldehyde: in vitro and in drosophila embryos. , 2000, Nucleic acids research.
[11] T. Tomonaga,et al. Activating transcription from single stranded DNA. , 1996, Proceedings of the National Academy of Sciences of the United States of America.
[12] R. Stroud,et al. Crystal structure of the third KH domain of human poly(C)-binding protein-2 in complex with a C-rich strand of human telomeric DNA at 1.6 Å resolution , 2007, Nucleic acids research.
[13] H. Krutzsch,et al. Cellular Nucleic Acid Binding Protein Regulates the CT Element of the Human c- myc Protooncogene (*) , 1995, The Journal of Biological Chemistry.
[14] L. Regan,et al. Structure and function of KH domains , 2008, The FEBS journal.
[15] M. Guéron,et al. A tetrameric DNA structure with protonated cytosine-cytosine base pairs , 1993, Nature.
[16] M. Abdelrahim,et al. Cyclooxygenase-2 Inhibitors Decrease Vascular Endothelial Growth Factor Expression in Colon Cancer Cells by Enhanced Degradation of Sp1 and Sp4 Proteins , 2005, Molecular Pharmacology.
[17] Brad Saville,et al. Estrogen regulation of vascular endothelial growth factor gene expression in ZR-75 breast cancer cells through interaction of estrogen receptor α and SP proteins , 2004, Oncogene.
[18] Yong You,et al. Predicting ultraviolet spectrum of single stranded and double stranded deoxyribonucleic acids. , 2008, Biophysical chemistry.
[19] Jerzy Ostrowski,et al. hnRNP K: One protein multiple processes , 2004, BioEssays : news and reviews in molecular, cellular and developmental biology.
[20] M. Abdelrahim,et al. Role of Sp Proteins in Regulation of Vascular Endothelial Growth Factor Expression and Proliferation of Pancreatic Cancer Cells , 2004, Cancer Research.
[21] M. Takagi,et al. Regulation of p53 Translation and Induction after DNA Damage by Ribosomal Protein L26 and Nucleolin , 2005, Cell.
[22] L. Marky,et al. Calorimetric unfolding of the bimolecular and i-motif complexes of the human telomere complementary strand, d(C(3)TA(2))(4). , 2007, Biophysical chemistry.
[23] Napoleone Ferrara,et al. Angiogenesis as a therapeutic target , 2005, Nature.
[24] K. Kihara,et al. Down-regulation of vascular endothelial growth factor in renal cell carcinoma cells by glucocorticoids , 2004, Molecular and Cellular Endocrinology.
[25] H. Leffers,et al. Identification of two human nuclear proteins that recognise the cytosine-rich strand of human telomeres in vitro. , 2000, Nucleic acids research.
[26] D. Patel,et al. Guanine residues in d(T2AG3) and d(T2G4) form parallel-stranded potassium cation stabilized G-quadruplexes with anti glycosidic torsion angles in solution. , 1992, Biochemistry.
[27] M. Borgognone,et al. Cellular nucleic-acid-binding protein, a transcriptional enhancer of c-Myc, promotes the formation of parallel G-quadruplexes. , 2010, The Biochemical journal.
[28] J. Abbruzzese,et al. Constitutive Sp1 activity is essential for differential constitutive expression of vascular endothelial growth factor in human pancreatic adenocarcinoma. , 2001, Cancer research.
[29] L. Hurley,et al. The proximal promoter region of the human vascular endothelial growth factor gene has a G-quadruplex structure that can be targeted by G-quadruplex–interactive agents , 2008, Molecular Cancer Therapeutics.
[30] Daniela Rhodes,et al. G-quadruplex structures: in vivo evidence and function. , 2009, Trends in cell biology.
[31] G. Siemeister,et al. Sp1 recognition sites in the proximal promoter of the human vascular endothelial growth factor gene are essential for platelet-derived growth factor-induced gene expression , 1997, Oncogene.
[32] Daekyu Sun,et al. Identification and Characterization of Nucleolin as a c-myc G-quadruplex-binding Protein* , 2009, The Journal of Biological Chemistry.
[33] G. Dreyfuss,et al. Specific binding of heterogeneous ribonucleoprotein particle protein K to the human c-myc promoter, in vitro. , 1993, The Journal of biological chemistry.